Department of Health and Social Care – Policy paper – 2019 voluntary scheme for branded medicines pricing and access: heads of agreement
The 2019 voluntary scheme for branded medicines pricing and access (voluntary scheme) is a non-contractual voluntary agreement between DHSC and ABPI.
The ABPI is the representative body of the pharmaceutical industry in the UK. It aims to provide stability and predictability for all parties in terms of the UK’s branded medicines expenditure and the medicines pricing and access environment for the period 2019 to 2023.
The voluntary scheme aims to achieve a balance between patient access, affordability and supporting the development of innovative new medicines, including support for small companies.
The heads of agreement sets out the key terms of the agreement reached between the parties on the voluntary scheme, and represents their commitment to continue to work together to reach the full agreement.
Published on the 21st november 2023. Read the full news story here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (21 mai 2024). Department of Health and Social Care – Policy paper – 2019 voluntary scheme for branded medicines pricing and access: heads of agreement. ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/11oz8